Hemostatic Profile of Post-COVID/Long-COVID Patients | Clinical Trial | StuddyBuddy@endsection Hemostatic Profile of Post-COVID/Long-COVID Patients
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05721066

Hemostatic Profile of Post-COVID/Long-COVID Patients

Conditions: COVID-19, Post-acute COVID-19 Syndrome

Sex: All
Ages: 18 Years – N/A
Enrollment: 102
Sponsor: IRCCS Policlinico S. Donato

Location: Italy

Summary

The present study aims at assessing long-term hemostatic profile of patients recovered from COVID-19 acute infection that remain asymptomatic (POST-COVID) versus patients with residual symptoms (LONG-COVID) through the employment of a commercially available new generation point-of-care viscoelastic device. The primary endpoint is based upon the hypothesis that patients with residual symptoms maintain an abnormal coagulation profile even after recovery from COVID-19.

Eligibility Criteria

Inclusion Criteria:age > 18 years;recovery from acute COVID-19 infection;COVID-19 pneumonia that required hospitalization in our Institution;discharge from the hospital minimum 3 months before the day of the visit;written consent to participate to the study.Exclusion Criteria:none.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05721066). StuddyBuddy aggregates publicly available trial information.